Articles by Sean Milmo - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Sean Milmo

Report from Europe

EMA and MHRA provide insight into increased GMP deficiencies.
Jul 2, 2012

EMA and MHRA provide insight into increased GMP deficiencies.

Report from Poland

Poland's government aims to make the Eastern European country a biotech powerhouse.
May 2, 2012

Poland's government aims to make the Eastern European country a biotech powerhouse.

Report from Europe

The European Union market takes steps toward continuous processing and modular facilities.
Jan 2, 2012

The European Union market takes steps toward continuous processing and modular facilities.

Report from Russia

Russia is aiming to provide an alternative to China and India for drug manufacturing, including APIs.
Nov 2, 2011

Russia is aiming to provide an alternative to China and India for drug manufacturing, including APIs.

Report from Europe

Member states in the EU are working to implement the newly passed Falsified Medicines Directive.
Jul 2, 2011

Member states in the EU are working to implement the newly passed Falsified Medicines Directive.

Report from Hungary

Eastern Europe's pharmaceutical leader, Hungary, is working to maintain its number-one status while also pursuing new avenues, especially in biopharmaceuticals.
May 2, 2011

Eastern Europe's pharmaceutical leader, Hungary, is working to maintain its number-one status while also pursuing new avenues, especially in biopharmaceuticals.

Report from Europe

The European Commission and Medicines Agency seem to be moving in advance of their ICH partners to update standards.
Jan 2, 2011

The European Commission and Medicines Agency seem to be moving in advance of their ICH partners to update standards.

Report from Europe

Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.
Oct 2, 2010

Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.

Report from Europe

Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.
Jun 2, 2010

Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here